NZ604135A - Method for purifying a fused pyrrolocarbazole derivative - Google Patents

Method for purifying a fused pyrrolocarbazole derivative

Info

Publication number
NZ604135A
NZ604135A NZ604135A NZ60413511A NZ604135A NZ 604135 A NZ604135 A NZ 604135A NZ 604135 A NZ604135 A NZ 604135A NZ 60413511 A NZ60413511 A NZ 60413511A NZ 604135 A NZ604135 A NZ 604135A
Authority
NZ
New Zealand
Prior art keywords
formula
theta
degrees
indazolo
carbazol
Prior art date
Application number
NZ604135A
Other languages
English (en)
Inventor
Shawn P Allwein
Arnaud Grandeury
Guy Piacenza
Sébastien Rose
Original Assignee
Cephalon Inc
Teva Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon Inc, Teva Sante filed Critical Cephalon Inc
Publication of NZ604135A publication Critical patent/NZ604135A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ604135A 2010-05-18 2011-05-17 Method for purifying a fused pyrrolocarbazole derivative NZ604135A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34583110P 2010-05-18 2010-05-18
PCT/US2011/036814 WO2011146488A1 (en) 2010-05-18 2011-05-17 Method for purifying a fused pyrrolocarbazole derivative

Publications (1)

Publication Number Publication Date
NZ604135A true NZ604135A (en) 2015-02-27

Family

ID=44168420

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ604135A NZ604135A (en) 2010-05-18 2011-05-17 Method for purifying a fused pyrrolocarbazole derivative

Country Status (20)

Country Link
US (1) US8884014B2 (enExample)
EP (1) EP2571885B1 (enExample)
JP (2) JP5828594B2 (enExample)
KR (1) KR101815332B1 (enExample)
CN (1) CN102958934B (enExample)
AU (1) AU2011256264B2 (enExample)
BR (1) BR112012029374B1 (enExample)
CA (1) CA2799517C (enExample)
CL (1) CL2012003208A1 (enExample)
EA (1) EA021869B1 (enExample)
ES (1) ES2530015T3 (enExample)
IL (2) IL223016A0 (enExample)
MX (1) MX2012013304A (enExample)
MY (1) MY156830A (enExample)
NZ (1) NZ604135A (enExample)
PH (1) PH12012502250A1 (enExample)
SG (2) SG185645A1 (enExample)
UA (1) UA108498C2 (enExample)
WO (1) WO2011146488A1 (enExample)
ZA (1) ZA201209305B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR074374A1 (es) 2008-11-19 2011-01-12 Cephalon Inc Formas de un compuesto de pirrolocarbazol fusionado, composiciones que las comprenden y su uso en el tratamiento de la angiogénesis y los tumores sólidos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200401316T4 (tr) * 2000-09-29 2004-07-21 Eli Lilly And Company Proliferatif hastalıkları tedavi etmek için yöntemler ve bileşikler
US7169802B2 (en) * 2003-12-23 2007-01-30 Cephalon, Inc. Fused pyrrolocarbazoles
JP2006241579A (ja) 2005-03-07 2006-09-14 Nippon Paint Co Ltd 化成処理剤及び表面処理金属
AR074374A1 (es) 2008-11-19 2011-01-12 Cephalon Inc Formas de un compuesto de pirrolocarbazol fusionado, composiciones que las comprenden y su uso en el tratamiento de la angiogénesis y los tumores sólidos.

Also Published As

Publication number Publication date
SG10201503541WA (en) 2015-06-29
BR112012029374A2 (pt) 2016-07-26
US20130123499A1 (en) 2013-05-16
KR101815332B1 (ko) 2018-01-04
AU2011256264A1 (en) 2013-01-10
WO2011146488A1 (en) 2011-11-24
ZA201209305B (en) 2014-02-26
IL242221B (en) 2018-06-28
IL242221A0 (en) 2015-11-30
US8884014B2 (en) 2014-11-11
CA2799517A1 (en) 2011-11-24
BR112012029374A8 (pt) 2017-12-26
CL2012003208A1 (es) 2013-05-17
ES2530015T3 (es) 2015-02-25
KR20140095116A (ko) 2014-08-01
CN102958934B (zh) 2015-06-17
SG185645A1 (en) 2012-12-28
MX2012013304A (es) 2013-04-03
IL223016A0 (en) 2013-02-03
BR112012029374B1 (pt) 2021-05-25
PH12012502250A1 (en) 2013-02-04
JP2016074668A (ja) 2016-05-12
AU2011256264B2 (en) 2016-09-15
EA201291269A1 (ru) 2013-05-30
CN102958934A (zh) 2013-03-06
CA2799517C (en) 2019-01-22
UA108498C2 (en) 2015-05-12
EP2571885B1 (en) 2014-11-12
EP2571885A1 (en) 2013-03-27
HK1182100A1 (en) 2013-11-22
EA021869B1 (ru) 2015-09-30
JP5828594B2 (ja) 2015-12-09
JP2013526573A (ja) 2013-06-24
MY156830A (en) 2016-03-31

Similar Documents

Publication Publication Date Title
NZ605627A (en) Pyrrolo-pyrazine derivatives useful as inhibitors of atr kinase
MY147440A (en) Process for making 3-substituted 2-amino-5-halobenzamides
EP4023641A3 (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
AU2015221439B2 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same
NZ734535A (en) Process of producing cycloalkylcarboxamido-indole compounds
NZ599306A (en) Process for the preparation of compounds useful as inhibitors of sglt2
NZ608285A (en) Manufacturing process for pyrimidine derivatives
WO2011117591A3 (en) Amine synergists and their use in radiation curing
MX2009003257A (es) Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina.
MX2011011245A (es) Proceso para la preparacion de compuestos de morfinano.
MX2014006992A (es) Disales de acido malonico y metodo para preparar dihaluros de malonilo.
PH12012501643A1 (en) Pyrazolopyrimidine compounds and their use as pde 10 inhibitors
IN2012DN01815A (enExample)
NZ730295A (en) Novel chiral synthesis of n-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines
PL1989174T3 (pl) Podstawione pochodne cykloheksylometylu
TW201129535A (en) Alcoholic hydroxyl-containing compounds and making method
WO2014003203A3 (en) Method for producing stereoselective epoxyketone compound
TW200720366A (en) Process for preparing metal compounds of an azo compound in the presence of seed crystals
NZ711327A (en) A process for preparation of (2s, 5r)-7-oxo-6-sulphooxy-2-[((3r)-piperidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo [3.2.1]- octane
WO2011102640A3 (en) Method for preparing sitagliptin and amine salt intermediates used therein
NZ604135A (en) Method for purifying a fused pyrrolocarbazole derivative
AR069778A1 (es) Proceso e intermediarios para la sintesis de piperizinas sustituidas heterociclicas con actividad antagonista de cxcr3
MX349740B (es) Proceso para la preparacion de fenilpropanonas sustituidas.
RU2007144740A (ru) Фотосенсибилизатор и способы его получения
MX2015011721A (es) Proceso para la preparacion de (2s,5r) -7-oxo-6-sulfooxi-2-[((3r)- pirrolidin-3-carbonil) carbonil hidrazino]-1,6-diaza-biciclo[3.2.1 ] octano.

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: CEPHALON, INC., US

Effective date: 20140904

Owner name: TEVA SANTE, FR

Effective date: 20140904

PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 17 MAY 2018 BY WATERMARK PATENT AND TRADE MARKS ATTORNEYS

Effective date: 20150528

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 MAY 2019 BY DENNEMEYER + CO

Effective date: 20180509

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 MAY 2020 BY DENNEMEYER + CO.

Effective date: 20190419

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 MAY 2021 BY DENNEMEYER + CO

Effective date: 20200505

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 MAY 2022 BY DENNEMEYER + CO.

Effective date: 20210510

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 MAY 2023 BY DENNEMEYER + CO. S.A.R.L.

Effective date: 20220509

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 MAY 2024 BY DENNEMEYER + CO. S.A.R.L.

Effective date: 20230508

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 MAY 2025 BY DENNEMEYER + CO.

Effective date: 20240506

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 MAY 2026 BY DENNEMEYER AND CO. SARL

Effective date: 20250505